Skip to main content
. 2021 Jun 18;46(5):494–503. doi: 10.1093/jat/bkab059

Table I.

Summary of Urinary Pharmacokinetic Outcomes across Cannabinoid Analytes following Administration of Oral and Vaporized CBD and CBD-dominant Cannabis

Sample information CBD 7-OH-CBD 7-CBD-COOH Δ9-THCCOOH
Condition Cmax (ng/mL) Tmax (h) Dose excreted (%) t1/2 (h) Cmax (ng/mL) Tmax (h) Dose excreted (%) t1/2 (h) Cmax (ng/mL) Tmax (h) Dose excreted (%) t1/2 (h) Cmax (ng/mL) Tmax (h)
Vaporized cannabis (100 mg CBD/3.7 mg THC) (n = 18) Mean 327.61 1.44 0.14 12.07 1,250.22 1.81 0.47 14.09 48.76 8.56 0.09 29.84 7.91 8.11
SD 235.53 1.06 0.10 11.13 1,479.93 1.13 0.40 4.88 40.72 9.82 0.06 11.65 8.46 8.51
Min 27.10 0.50 0.01 0.69 142.00 0.50 0.08 2.41 4.76 1.00 0.01 11.31 1.20 1.00
Max 808.50 4.00 0.39 40.66 5,073.04 4.00 1.56 24.27 172.30 31.00 0.18 51.00 29.90 31.00
100 mg vaporized pure CBD (n = 18) Mean 239.95 1.28 0.11 7.27 677.40 1.75 0.32 11.82 29.39 7.17 0.06 29.63 0.43 ND
SD 240.37 1.13 0.10 7.73 596.37 0.91 0.25 6.30 19.17 5.95 0.05 24.49 1.22 ND
Min 15.30 0.50 0.01 0.78 78.20 0.50 0.04 0.82 2.91 1.00 0.00 5.11 0.00 ND
Max 1,007.90 4.00 0.44 23.69 2,041.80 3.00 0.92 23.33 65.80 16.00 0.16 107.47 5.00 4.00
100 mg oral CBD capsule (n = 6) Mean 776.25 5.33 0.38 11.16 3,588.22 5.50 2.04 11.74 75.07 15.33 0.23 82.03 0.70 ND
SD 1,069.56 3.01 0.39 5.72 3,753.74 2.95 1.96 4.41 55.64 8.21 0.26 108.94 1.20 ND
Min 210.20 2.00 0.04 4.29 373.26 2.00 0.24 7.72 25.22 4.00 0.03 12.64 0.00 ND
Max 2,941.00 9.00 1.16 17.91 9,944.19 9.00 4.53 19.67 157.62 28.00 0.73 300.91 2.90 1.50
100 mg oral CBD syrup (n = 6) Mean 150.57 4.33 0.12 11.39 1,075.00 4.00 0.81 19.06 79.93 15.17 0.13 48.96 0.32 ND
SD 77.81 1.75 0.08 7.78 999.20 1.10 0.45 15.58 86.79 12.84 0.05 58.98 0.78 ND
Min 68.70 2.00 0.04 3.33 238.50 2.00 0.30 7.82 14.80 5.00 0.10 15.05 0.00 ND
Max 228.90 7.00 0.26 25.94 2,734.80 5.00 1.49 49.33 239.20 40.00 0.24 167.17 1.90 BL
100 mg oral Epidiolex (n = 6) Mean 1,273.83 4.33 0.50 10.78 5,849.10 4.50 2.53 13.36 324.75 13.00 0.62 24.59 0.20 ND
SD 1,168.15 0.52 0.37 2.48 3,588.11 0.55 0.81 5.52 113.18 7.77 0.25 8.97 0.49 ND
Min 368.10 4.00 0.15 6.46 3,527.20 4.00 1.52 7.25 190.60 4.00 0.20 16.91 0.00 ND
Max 3,470.20 5.00 1.08 13.20 12,898.30 5.00 3.84 22.29 520.20 24.00 0.89 41.79 1.20 17.00
100 mg oral CBD (formulations combined) (n = 18) Mean 733.55 4.67 0.34 11.11 3,504.11 4.67 1.79 14.72 159.92 14.50 0.33 51.86 0.41 ND
SD 981.43 1.97 0.34 5.41 3,500.06 1.85 1.39 9.82 145.88 9.34 0.29 71.58 0.85 ND
Min 68.70 2.00 0.04 3.33 238.50 2.00 0.24 7.25 14.80 4.00 0.03 12.64 0.00 ND
Max 3,470.20 9.00 1.16 25.94 12,898.30 9.00 4.53 49.33 520.20 40.00 0.89 300.91 2.90 17.00
100 mg oral CBD syrup (overnight fasting) (n = 6) Mean 167.88 4.00 0.07 35.24 605.38 4.00 0.28 49.84 32.58 16.33 0.05 105.45 0.00 ND
SD 212.62 1.10 0.06 23.69 578.48 1.10 0.10 45.43 22.04 18.60 0.02 84.64 0.00 ND
Min 14.90 2.00 0.02 5.22 80.40 2.00 0.16 7.43 13.80 4.00 0.02 23.33 0.00 ND
Max 572.50 5.00 0.15 65.42 1,358.20 5.00 0.39 125.38 60.20 52.00 0.08 231.47 0.00 ND

ND = analyte was not detected for some participants/conditions, which precluded mean Tmax calculation. BL = baseline. Midpoint time value used for pooled specimens. For dose excreted (%), values are corrected for the molecular weight of the analyte.